Gene Therapy for HIV From Inception to a Possible Cure

This Brief describes the concept and realization of gene therapy for HIV from the unique historic perspective and insight of two pioneers of the clinical applications of stem cell gene therapy for HIV. Gerhard Bauer applied ribozyme-anti-HIV and other vectors to manufacture clinical grade, HIV-resis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bauer, Gerhard (VerfasserIn), Anderson, Joseph S. (VerfasserIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: New York, NY [u.a.] Springer 2014
Schriftenreihe:SpringerBriefs in Biochemistry and Molecular Biology
Schlagworte:
Online-Zugang:DE-91
DE-703
Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 c 4500
001 BV041733777
003 DE-604
005 00000000000000.0
007 cr|uuu---uuuuu
008 140313s2014 xx o|||| 00||| eng d
020 |a 9781493904341  |c Online  |9 978-1-4939-0434-1 
024 7 |a 10.1007/978-1-4939-0434-1  |2 doi 
035 |a (OCoLC)871042065 
035 |a (DE-599)GBV779689860 
040 |a DE-604  |b ger  |e aacr 
041 0 |a eng 
049 |a DE-703  |a DE-91 
050 0 |a RB155.8 
082 0 |a 615.895 
084 |a BIO 000  |2 stub 
100 1 |a Bauer, Gerhard  |e Verfasser  |4 aut 
245 1 0 |a Gene Therapy for HIV  |b From Inception to a Possible Cure  |c Gerhard Bauer ; Joseph S. Anderson 
264 1 |a New York, NY [u.a.]  |b Springer  |c 2014 
300 |a 1 Online-Ressource 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
338 |b cr  |2 rdacarrier 
490 0 |a SpringerBriefs in Biochemistry and Molecular Biology 
520 1 |a This Brief describes the concept and realization of gene therapy for HIV from the unique historic perspective and insight of two pioneers of the clinical applications of stem cell gene therapy for HIV. Gerhard Bauer applied ribozyme-anti-HIV and other vectors to manufacture clinical grade, HIV-resistant hematopoietic stem cells for the first patients that received stem cell gene therapy for HIV, including the first child in the world and the first fully marrow-ablated HIV infected patient. Joseph Anderson developed the most recent and most potent combination anti-HIV lentiviral vectors and pluripotent stem cell applications for HIV gene therapy and tested these in the appropriate in vitro and vivo models, paving the way for novel HIV gene therapy approaches to possibly cure patients. In Gene Therapy for HIV, Bauer and Anderson discuss the unique aspects of this therapy, including its limitations and proper safety precautions and outline a path for a possible functional cure for HIV using stem cell gene therapy based on a cure already achieved with a bone marrow stem cell transplantation performed in Germany using donor stem cells with a naturally arising CCR5 mutation. In addition, the Brief provides a thorough and methodical explanation of the basics of gene therapy, gene therapy vector development, in vitro and in vivo models for HIV gene therapy and clinical applications of HIV gene therapy, including Good Manufacturing Practices 
650 4 |a Medizin 
650 4 |a Medicine 
650 4 |a Gene therapy 
650 4 |a Immunology 
650 4 |a Vaccines 
650 4 |a Medical virology 
700 1 |a Anderson, Joseph S.  |e Verfasser  |4 aut 
776 0 8 |i Erscheint auch als  |n Druckausgabe  |z 978-1-4939-0433-4 
856 4 0 |u https://doi.org/10.1007/978-1-4939-0434-1  |x Verlag  |3 Volltext 
912 |a ZDB-2-SBL 
943 1 |a oai:aleph.bib-bvb.de:BVB01-027180511 
966 e |u https://doi.org/10.1007/978-1-4939-0434-1  |l DE-91  |p ZDB-2-SBL  |x Verlag  |3 Volltext 
966 e |u https://doi.org/10.1007/978-1-4939-0434-1  |l DE-703  |p ZDB-2-SBL  |x Verlag  |3 Volltext 

Datensatz im Suchindex

_version_ 1819293042425724929
any_adam_object
author Bauer, Gerhard
Anderson, Joseph S.
author_facet Bauer, Gerhard
Anderson, Joseph S.
author_role aut
aut
author_sort Bauer, Gerhard
author_variant g b gb
j s a js jsa
building Verbundindex
bvnumber BV041733777
callnumber-first R - Medicine
callnumber-label RB155
callnumber-raw RB155.8
callnumber-search RB155.8
callnumber-sort RB 3155.8
callnumber-subject RB - Pathology
classification_tum BIO 000
collection ZDB-2-SBL
ctrlnum (OCoLC)871042065
(DE-599)GBV779689860
dewey-full 615.895
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 615 - Pharmacology and therapeutics
dewey-raw 615.895
dewey-search 615.895
dewey-sort 3615.895
dewey-tens 610 - Medicine and health
discipline Biologie
Medizin
doi_str_mv 10.1007/978-1-4939-0434-1
format Electronic
eBook
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03016nam a2200469 c 4500</leader><controlfield tag="001">BV041733777</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">140313s2014 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781493904341</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4939-0434-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4939-0434-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)871042065</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV779689860</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RB155.8</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.895</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIO 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bauer, Gerhard</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gene Therapy for HIV</subfield><subfield code="b">From Inception to a Possible Cure</subfield><subfield code="c">Gerhard Bauer ; Joseph S. Anderson</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">SpringerBriefs in Biochemistry and Molecular Biology</subfield></datafield><datafield tag="520" ind1="1" ind2=" "><subfield code="a">This Brief describes the concept and realization of gene therapy for HIV from the unique historic perspective and insight of two pioneers of the clinical applications of stem cell gene therapy for HIV. Gerhard Bauer applied ribozyme-anti-HIV and other vectors to manufacture clinical grade, HIV-resistant hematopoietic stem cells for the first patients that received stem cell gene therapy for HIV, including the first child in the world and the first fully marrow-ablated HIV infected patient. Joseph Anderson developed the most recent and most potent combination anti-HIV lentiviral vectors and pluripotent stem cell applications for HIV gene therapy and tested these in the appropriate in vitro and vivo models, paving the way for novel HIV gene therapy approaches to possibly cure patients. In Gene Therapy for HIV, Bauer and Anderson discuss the unique aspects of this therapy, including its limitations and proper safety precautions and outline a path for a possible functional cure for HIV using stem cell gene therapy based on a cure already achieved with a bone marrow stem cell transplantation performed in Germany using donor stem cells with a naturally arising CCR5 mutation. In addition, the Brief provides a thorough and methodical explanation of the basics of gene therapy, gene therapy vector development, in vitro and in vivo models for HIV gene therapy and clinical applications of HIV gene therapy, including Good Manufacturing Practices</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical virology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anderson, Joseph S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-4939-0433-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4939-0434-1</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027180511</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-0434-1</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-0434-1</subfield><subfield code="l">DE-703</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection>
id DE-604.BV041733777
illustrated Not Illustrated
indexdate 2024-12-24T04:04:08Z
institution BVB
isbn 9781493904341
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-027180511
oclc_num 871042065
open_access_boolean
owner DE-703
DE-91
DE-BY-TUM
owner_facet DE-703
DE-91
DE-BY-TUM
physical 1 Online-Ressource
psigel ZDB-2-SBL
publishDate 2014
publishDateSearch 2014
publishDateSort 2014
publisher Springer
record_format marc
series2 SpringerBriefs in Biochemistry and Molecular Biology
spelling Bauer, Gerhard Verfasser aut
Gene Therapy for HIV From Inception to a Possible Cure Gerhard Bauer ; Joseph S. Anderson
New York, NY [u.a.] Springer 2014
1 Online-Ressource
txt rdacontent
c rdamedia
cr rdacarrier
SpringerBriefs in Biochemistry and Molecular Biology
This Brief describes the concept and realization of gene therapy for HIV from the unique historic perspective and insight of two pioneers of the clinical applications of stem cell gene therapy for HIV. Gerhard Bauer applied ribozyme-anti-HIV and other vectors to manufacture clinical grade, HIV-resistant hematopoietic stem cells for the first patients that received stem cell gene therapy for HIV, including the first child in the world and the first fully marrow-ablated HIV infected patient. Joseph Anderson developed the most recent and most potent combination anti-HIV lentiviral vectors and pluripotent stem cell applications for HIV gene therapy and tested these in the appropriate in vitro and vivo models, paving the way for novel HIV gene therapy approaches to possibly cure patients. In Gene Therapy for HIV, Bauer and Anderson discuss the unique aspects of this therapy, including its limitations and proper safety precautions and outline a path for a possible functional cure for HIV using stem cell gene therapy based on a cure already achieved with a bone marrow stem cell transplantation performed in Germany using donor stem cells with a naturally arising CCR5 mutation. In addition, the Brief provides a thorough and methodical explanation of the basics of gene therapy, gene therapy vector development, in vitro and in vivo models for HIV gene therapy and clinical applications of HIV gene therapy, including Good Manufacturing Practices
Medizin
Medicine
Gene therapy
Immunology
Vaccines
Medical virology
Anderson, Joseph S. Verfasser aut
Erscheint auch als Druckausgabe 978-1-4939-0433-4
https://doi.org/10.1007/978-1-4939-0434-1 Verlag Volltext
spellingShingle Bauer, Gerhard
Anderson, Joseph S.
Gene Therapy for HIV From Inception to a Possible Cure
Medizin
Medicine
Gene therapy
Immunology
Vaccines
Medical virology
title Gene Therapy for HIV From Inception to a Possible Cure
title_auth Gene Therapy for HIV From Inception to a Possible Cure
title_exact_search Gene Therapy for HIV From Inception to a Possible Cure
title_full Gene Therapy for HIV From Inception to a Possible Cure Gerhard Bauer ; Joseph S. Anderson
title_fullStr Gene Therapy for HIV From Inception to a Possible Cure Gerhard Bauer ; Joseph S. Anderson
title_full_unstemmed Gene Therapy for HIV From Inception to a Possible Cure Gerhard Bauer ; Joseph S. Anderson
title_short Gene Therapy for HIV
title_sort gene therapy for hiv from inception to a possible cure
title_sub From Inception to a Possible Cure
topic Medizin
Medicine
Gene therapy
Immunology
Vaccines
Medical virology
topic_facet Medizin
Medicine
Gene therapy
Immunology
Vaccines
Medical virology
url https://doi.org/10.1007/978-1-4939-0434-1
work_keys_str_mv AT bauergerhard genetherapyforhivfrominceptiontoapossiblecure
AT andersonjosephs genetherapyforhivfrominceptiontoapossiblecure